SAN FRANCISCO, Calif., March 28, 2024 /PRNewswire/ — Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse demographics.
„As an organization, we have been committed to diversity in clinical trials since day one,“ said Kyle Burtnett, CEO of Headlands Research. „Our partnership with Pfizer has been a critical component in our continued goal of making clinical research accessible to all.“
主页
